+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuromodulation Market Research Report by Technology, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5123704
  • Report
  • September 2021
  • Region: United States
  • 63 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The United States Neuromodulation Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Neuromodulation Market.

Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Neuromodulation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the Neuromodulation Market was studied across Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
  • Based on Application, the Neuromodulation Market was studied across Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, Obsessive Compulsive Disorder, Parkinson’s Disease, Refractory Epilepsy, Treatment Resistant Depression, and Urinary Fecal Incontinence.
  • Based on State, the Neuromodulation Market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuromodulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Neuromodulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Neuromodulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Neuromodulation Market?
4. What is the competitive strategic window for opportunities in the United States Neuromodulation Market?
5. What are the technology trends and regulatory frameworks in the United States Neuromodulation Market?
6. What is the market share of the leading vendors in the United States Neuromodulation Market?
7. What modes and strategic moves are considered suitable for entering the United States Neuromodulation Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Technology Outlook
3.4. Application Outlook
3.5. State Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Neuromodulation Market, by Technology
6.1. Introduction
6.2. Deep Brain Stimulation
6.3. Gastric Stimulation
6.4. Sacral Nerve Stimulation
6.5. Spinal Cord Stimulation
6.6. Vagus Nerve Stimulation

7. Neuromodulation Market, by Application
7.1. Introduction
7.2. Chronic Pain
7.3. Dystonia
7.4. Essential Tremor
7.5. Gastroparesis
7.6. Obsessive Compulsive Disorder
7.7. Parkinson’s Disease
7.8. Refractory Epilepsy
7.9. Treatment Resistant Depression
7.10. Urinary Fecal Incontinence

8. California Neuromodulation Market
8.1. Introduction

9. Florida Neuromodulation Market
9.1. Introduction

10. Illinois Neuromodulation Market
10.1. Introduction

11. New York Neuromodulation Market
11.1. Introduction

12. Ohio Neuromodulation Market
12.1. Introduction

13. Pennsylvania Neuromodulation Market
13.1. Introduction

14. Texas Neuromodulation Market
14.1. Introduction

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES NEUROMODULATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
FIGURE 3. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 5. UNITED STATES NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 6. UNITED STATES NEUROMODULATION MARKET: MARKET DYNAMICS
FIGURE 7. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 8. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, 2018-2026 (USD MILLION)
FIGURE 11. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, 2018-2026 (USD MILLION)
FIGURE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 14. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 21. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2026
FIGURE 23. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, 2018-2026 (USD MILLION)
FIGURE 32. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 33. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON’S DISEASE, 2018-2026 (USD MILLION)
FIGURE 34. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON’S DISEASE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 35. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, 2018-2026 (USD MILLION)
FIGURE 36. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 37. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, 2018-2026 (USD MILLION)
FIGURE 38. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 39. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, 2018-2026 (USD MILLION)
FIGURE 40. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 41. CALIFORNIA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. FLORIDA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. ILLINOIS NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. NEW YORK NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. OHIO NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. PENNSYLVANIA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. TEXAS NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. UNITED STATES NEUROMODULATION MARKET: FPNV POSITIONING MATRIX
FIGURE 49. UNITED STATES NEUROMODULATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 50. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NEUROMODULATION MARKET, BY TYPE

List of Tables
TABLE 1. UNITED STATES NEUROMODULATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES NEUROMODULATION MARKET SIZE, BY PARKINSON’S DISEASE, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY STATE, 2018-2026 (USD MILLION)
TABLE 20. CALIFORNIA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. FLORIDA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. ILLINOIS NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. NEW YORK NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. OHIO NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. PENNSYLVANIA NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. TEXAS NEUROMODULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. UNITED STATES NEUROMODULATION MARKET: SCORES
TABLE 28. UNITED STATES NEUROMODULATION MARKET: BUSINESS STRATEGY
TABLE 29. UNITED STATES NEUROMODULATION MARKET: PRODUCT SATISFACTION
TABLE 30. UNITED STATES NEUROMODULATION MARKET: RANKING
TABLE 31. UNITED STATES NEUROMODULATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 32. UNITED STATES NEUROMODULATION MARKET: MERGER & ACQUISITION
TABLE 33. UNITED STATES NEUROMODULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 34. UNITED STATES NEUROMODULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 35. UNITED STATES NEUROMODULATION MARKET: INVESTMENT & FUNDING
TABLE 36. UNITED STATES NEUROMODULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 37. UNITED STATES NEUROMODULATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll